Disclosed are (2R,3R)-3-(3-substituted phenyl)-2-methyl-n-pentanamide compounds shown as formula I, their preparation methods thereof, wherein the substituents are described in the description, and their uses in the manufacture of Tapentatol II or its pharmaceutically acceptable salts. Also disclosed are the intermediates in the preparation process.